Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Pozycja w akcjach #33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Cena akcji
$0.5475
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$6.71M
Zmiana (1 dzień)
5.57%
Zmiana (1 rok)
-
Kraj
US
Handel 20/20 Biolabs Inc. (AIDX)

Kategoria

Historia stopy dywidendy dla 20/20 Biolabs Inc. (AIDX)
Stopa dywidendy (TTM) dla 20/20 Biolabs Inc. (symbol akcji: AIDX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla 20/20 Biolabs Inc. (AIDX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji